Diaceutics can help pharma clients conduct real world evidence studies for their targeted therapy assets. We leverage our medical record database, global laboratory network and customized surveys to understand the current treatment and diagnostic testing practices. Unlike clinical trials, which are controlled, real world studies are conducted to gain insight into how diagnostic testing can affect treatment decision-making, identifying which factors or parameters could impact the quality, accuracy and performance of the assay in real world situations. These analyses enable pharma stakeholders to make informed strategic investment decisions.